dRx Capital
Profile, fund size and portfolio
dRx Capital is the corporate venture arm of Novartis, a pharmaceutical and biotech company. It was founded in 2015 and is based in Basel, Switzerland. It invests from seed to Series A. Sectors it names: healthcare and digital health.
- Commitment by parentS1
- USD 100M
Every figure links to its source
Snapshot
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | USD 100M | Commitment by parent | Stated by the firm or its parent | S1 |
| Companies on the firm's portfolio page | 5 | companies | Counted from the firm's own list | S7 |
Sources: S1 Lenz & Staehelin: Qualcomm Incorporated and Novartis launched dRx Capital; S7 PR Newswire: Science 37 secures 6.5M Series A co-led by Lux Capital and dRx Capital.
Where it invests and who leads it
Geography
- Headquarters
- Basel, Switzerland
- Offices
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Novartis | Reported by aVenture: dRx Capital | S2 |
| Parent industry | Pharmaceuticals and biotech | Reported by aVenture: dRx Capital | S2 |
| Founded | 2015 | Single source | S1 |
| Headquarters | Basel, Switzerland | Reported by aVenture: dRx Capital | S2 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | USD 100M (Commitment by parent) | Single source | S1 |
| Stages | Seed, Series A (inferred from announced rounds) | Estimate | S1 |
Recent rounds
History
Portfolio
Public sources name 5 portfolio companies.S7
Every company on the dRx Capital list
5 companies, as named in the sources cited.S7 Read the firm's list.
- Holmusk
- Omada Health
- RxLightning
- Science 37
- Yseop
Official pages
Read the firm's own pages for current information.
- Website drxcapital.com/
Sources
- S1Lenz & Staehelin: Qualcomm Incorporated and Novartis launched dRx CapitalPress
- S2aVenture: dRx Capital, BaselThird-party report
- S3FundingWatcher corporate venture capital investor listThird-party report
- S4Novartis: joint investment company with Qualcomm Ventures of up to USD 100 million (Basel, 2015-01-12)Firm
- S5dRx Capital websiteFirm
- S6Global Corporate Venturing: GCV Symposium 2021 panel on digital health (Rana Lonnen, dRx Capital)Press
- S7PR Newswire: Science 37 secures 6.5M Series A co-led by Lux Capital and dRx CapitalPortfolio company
- S8RxLightning: closes 17.5M Series A (Novartis dRx Capital participating)Portfolio company
- S9Yseop: strategic investment round with Novartis (dRx Capital)Portfolio company
- S10PR Newswire (Holmusk): strategic investment round with Novartis (dRx Capital)Portfolio company
- S11Global Corporate Venturing: Omada aligns with corporates for 73m round (dRx Capital invested)Press
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by dRx Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.